Resurrected Mammoths and Dodos? Don't Count on it
By David Ehrenfeld,
The Guardian
| 03. 23. 2013
I recently spoke at
Revive & Restore's
TEDx DeExtinction event at the National Geographic headquarters in Washington DC. Most of the speakers were brilliant geneticists working on ways to revive species that no longer live on earth by injecting DNA from extinct species into eggs of living relatives. The atmosphere was electric with the hopes and claims of top scientists bent on bringing back the
woolly mammoth, the passenger pigeon, and other vanished species. I was the invited skeptic, and here's what I told them, more or less.
The poster child for de-extinction is
the passenger pigeon. The first European visitors to North America saw flocks so huge that they darkened the skies from horizon to horizon. Even in the 19th century, when the pigeons were starting to decline, observers estimated over a billion birds in some flocks. A market hunter with a shotgun could kill 50 or 100 with a single shot. The combined weight of the pigeons could bring down giant tree limbs with a sound like cannon fire. Yet the last passenger pigeon, a...
Related Articles
By Isaac Schultz, Gizmodo | 10.18.2024
Colossal Biosciences, a company mainly known for intending to genetically engineer proxies for several iconic extinct species, announced this week that it has made major steps towards the de-extinction of the thylacine, or Tasmanian tiger.
The thylacine was a carnivorous...
By Russ Burlingame, Comicbook | 07.23.2024
Colossal Laboratories and Biosciences, a biotech company that's putting together plans to orchestrate the de-extinction for animals like the dodo and the wooly mammoth, made some waves on Reddit recently when they petitioned the United Federation of Planets -- the...
By Shelly Fan, Singularity Hub | 05.31.2024
We all know the drill for reproduction—sperm meets egg.
For the past decade, scientists have been pushing the boundaries of where the two halves come from. Thanks to induced pluripotent stem cell technology, it’s now possible to scrape skin cells...
By Alison Snyder, Axios | 06.06.2024
Gene editing's next chapter will be focused on tackling cancers and more common diseases, uncovering new details about aging and other fundamental aspects of biology and editing RNA, top scientists in the field said this week.
The big picture: ...